2022 Q1 Form 10-Q Financial Statement

#000140658722000070 Filed on April 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $421.6M $287.1M
YoY Change 46.85% 80.45%
Cost Of Revenue $334.1M $233.8M
YoY Change 42.9% 71.16%
Gross Profit $87.50M $53.30M
YoY Change 64.17% 136.89%
Gross Profit Margin 20.75% 18.56%
Selling, General & Admin $24.30M $16.30M
YoY Change 49.08% 45.54%
% of Gross Profit 27.77% 30.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $500.0K $700.0K
YoY Change -28.57% -53.33%
% of Gross Profit 0.57% 1.31%
Operating Expenses $24.30M $16.30M
YoY Change 49.08% 45.54%
Operating Profit $63.20M $37.00M
YoY Change 70.81% 227.43%
Interest Expense $0.00 $600.0K
YoY Change -100.0% -71.43%
% of Operating Profit 0.0% 1.62%
Other Income/Expense, Net
YoY Change
Pretax Income $63.20M $37.60M
YoY Change 68.09% 174.45%
Income Tax $15.40M $9.200M
% Of Pretax Income 24.37% 24.47%
Net Earnings $47.80M $28.40M
YoY Change 68.31% 195.83%
Net Earnings / Revenue 11.34% 9.89%
Basic Earnings Per Share $0.96 $0.59
Diluted Earnings Per Share $0.96 $0.59
COMMON SHARES
Basic Shares Outstanding 49.82M shares 48.41M shares
Diluted Shares Outstanding 49.88M shares 48.51M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $233.7M $167.2M
YoY Change 39.77% -61.84%
Cash & Equivalents $233.7M $167.2M
Short-Term Investments
Other Short-Term Assets $10.20M $5.300M
YoY Change 92.45% 20.45%
Inventory
Prepaid Expenses
Receivables $300.0K $3.200M
Other Receivables $0.00 $0.00
Total Short-Term Assets $244.2M $175.7M
YoY Change 38.99% -60.39%
LONG-TERM ASSETS
Property, Plant & Equipment $5.000M $2.000M
YoY Change 150.0% 100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $500.0K $900.0K
YoY Change -44.44% -84.21%
Other Assets
YoY Change
Total Long-Term Assets $1.987B $1.723B
YoY Change 15.33% 39.87%
TOTAL ASSETS
Total Short-Term Assets $244.2M $175.7M
Total Long-Term Assets $1.987B $1.723B
Total Assets $2.232B $1.899B
YoY Change 17.52% 13.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.60M $39.80M
YoY Change 39.7% 72.29%
Accrued Expenses $158.0M $98.90M
YoY Change 59.76% 67.63%
Deferred Revenue $17.70M $200.0K
YoY Change 8750.0% -93.55%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $370.2M $281.7M
YoY Change 31.42% 54.19%
LONG-TERM LIABILITIES
Long-Term Debt $705.3M $654.6M
YoY Change 7.75% 2.27%
Other Long-Term Liabilities $25.70M $10.70M
YoY Change 140.19% 62.12%
Total Long-Term Liabilities $731.0M $665.3M
YoY Change 9.88% 2.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $370.2M $281.7M
Total Long-Term Liabilities $731.0M $665.3M
Total Liabilities $1.124B $954.4M
YoY Change 17.79% 13.78%
SHAREHOLDERS EQUITY
Retained Earnings $417.4M $269.3M
YoY Change 54.99% 45.88%
Common Stock $689.0M $674.4M
YoY Change 2.16% 3.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.106B $943.7M
YoY Change
Total Liabilities & Shareholders Equity $2.232B $1.899B
YoY Change 17.52% 13.33%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $47.80M $28.40M
YoY Change 68.31% 195.83%
Depreciation, Depletion And Amortization $500.0K $700.0K
YoY Change -28.57% -53.33%
Cash From Operating Activities $70.80M -$90.80M
YoY Change -177.97% -19.07%
INVESTING ACTIVITIES
Capital Expenditures -$1.000M -$100.0K
YoY Change 900.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $100.0K
YoY Change -100.0% -83.33%
Cash From Investing Activities -$1.000M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.400M 20.60M
YoY Change -93.2% -88.34%
NET CHANGE
Cash From Operating Activities 70.80M -90.80M
Cash From Investing Activities -1.000M 0.000
Cash From Financing Activities 1.400M 20.60M
Net Change In Cash 71.20M -70.20M
YoY Change -201.42% -208.17%
FREE CASH FLOW
Cash From Operating Activities $70.80M -$90.80M
Capital Expenditures -$1.000M -$100.0K
Free Cash Flow $71.80M -$90.70M
YoY Change -179.16% -19.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei City Area Code
CityAreaCode
817
dei Entity Central Index Key
EntityCentralIndexKey
0001406587
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33662
dei Entity Registrant Name
EntityRegistrantName
FORESTAR GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1336998
dei Entity Address Address Line1
EntityAddressAddressLine1
2221 E. Lamar Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 790
dei Entity Address City Or Town
EntityAddressCityOrTown
Arlington
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76006
dei Local Phone Number
LocalPhoneNumber
769-1860
dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
dei Trading Symbol
TradingSymbol
FOR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49738344 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233700000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153600000 USD
CY2022Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1960500000 USD
CY2021Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1905200000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
500000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
900000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000000.0 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2900000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
31900000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
39100000 USD
CY2022Q1 us-gaap Assets
Assets
2231600000 USD
CY2021Q3 us-gaap Assets
Assets
2101700000 USD
CY2022Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
55600000 USD
CY2021Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
47400000 USD
CY2022Q1 for Accrued Development Costs
AccruedDevelopmentCosts
120600000 USD
CY2021Q3 for Accrued Development Costs
AccruedDevelopmentCosts
104500000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
141900000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
148300000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
23000000.0 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24400000 USD
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
77800000 USD
CY2021Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
56700000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
705300000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
704500000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1124200000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1085800000 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49738344 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49580389 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
49700000 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
49600000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
639300000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
636200000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
417400000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
329100000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1106400000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1014900000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
1000000.0 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
1000000.0 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1107400000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1015900000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2231600000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2101700000 USD
CY2022Q1 us-gaap Revenues
Revenues
421600000 USD
CY2021Q1 us-gaap Revenues
Revenues
287100000 USD
us-gaap Revenues
Revenues
829200000 USD
us-gaap Revenues
Revenues
594200000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
334100000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
233800000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
668300000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
496700000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24300000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16300000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45800000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31800000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
500000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
500000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49900000 shares
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
800000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63200000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37600000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66800000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15400000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16300000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
47800000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
28400000 USD
us-gaap Profit Loss
ProfitLoss
88300000 USD
us-gaap Profit Loss
ProfitLoss
50500000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
100000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
47800000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
28400000 USD
us-gaap Net Income Loss
NetIncomeLoss
88300000 USD
us-gaap Net Income Loss
NetIncomeLoss
50400000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.96
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49800000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48300000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48400000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49580389 shares
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1015900000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
40500000 USD
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1700000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2021Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
400000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1058400000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
47800000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
400000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1600000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1107400000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
871800000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
22100000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
300000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
894100000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
28400000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1018503 shares
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23300000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
1900000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
300000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
900000 USD
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49124801 shares
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
944500000 USD
us-gaap Profit Loss
ProfitLoss
88300000 USD
us-gaap Profit Loss
ProfitLoss
50500000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1300000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1500000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1400000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2200000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1200000 USD
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
6000000.0 USD
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
900000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
500000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
61100000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
377300000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3800000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6500000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
29400000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25600000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
16100000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3600000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-6200000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
42800000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-6300000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76600000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-249500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
200000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1500000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2200000 USD
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
3200000 USD
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2000000.0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1700000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23300000 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0 USD
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-2400000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
100000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
400000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1300000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20400000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
80100000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-227100000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153600000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
394300000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233700000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167200000 USD
us-gaap Notes Issued1
NotesIssued1
0 USD
us-gaap Notes Issued1
NotesIssued1
12500000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Presentation and Reclassifications </span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reclassified the change in accrued development costs from the change in accounts payable and other liabilities to the change in accrued development costs in the prior year statement of cash flows to conform to the current year presentation. This reclassification had no net effect on the Company's consolidated operating results, financial position or cash flows.</span></div>
CY2022Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1960500000 USD
CY2021Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1905200000 USD
us-gaap Payments To Acquire Residential Real Estate
PaymentsToAcquireResidentialRealEstate
220400000 USD
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
495400000 USD
CY2022Q1 for Real Estate Carrying Value
RealEstateCarryingValue
8800000 USD
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3800000 USD
CY2022Q1 for Due Diligence Write Offs
DueDiligenceWriteOffs
1600000 USD
for Due Diligence Write Offs
DueDiligenceWriteOffs
2200000 USD
CY2021Q1 for Due Diligence Write Offs
DueDiligenceWriteOffs
600000 USD
for Due Diligence Write Offs
DueDiligenceWriteOffs
900000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12500000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12500000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 USD
CY2022Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
100000 USD
CY2021Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
6900000 USD
us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
3600000 USD
us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
7100000 USD
CY2022Q1 us-gaap Revenues
Revenues
421600000 USD
CY2021Q1 us-gaap Revenues
Revenues
287100000 USD
us-gaap Revenues
Revenues
829200000 USD
us-gaap Revenues
Revenues
594200000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12500000 USD
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
52900000 USD
CY2020Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
51000000.0 USD
CY2021Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
53700000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
48700000 USD
CY2022Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
8100000 USD
CY2021Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
11500000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
16300000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
23000000.0 USD
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
10400000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
8200000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
19400000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
17400000 USD
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
50600000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
54300000 USD
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
50600000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
54300000 USD
CY2022Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
400000 USD
CY2021Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
700000 USD
CY2022Q1 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
300000 USD
CY2021Q3 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
400000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8000000.0 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6900000 USD
CY2022Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
10200000 USD
CY2021Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
15400000 USD
CY2022Q1 us-gaap Deposits Assets
DepositsAssets
11100000 USD
CY2021Q3 us-gaap Deposits Assets
DepositsAssets
10400000 USD
CY2022Q1 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
1900000 USD
CY2021Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
5300000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
31900000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
39100000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
9400000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
7900000 USD
CY2022Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
2300000 USD
CY2021Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
3400000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8500000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7300000 USD
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7700000 USD
CY2021Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
8500000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17700000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5800000 USD
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
6800000 USD
CY2021Q3 us-gaap Deferred Revenue
DeferredRevenue
6800000 USD
CY2022Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
14700000 USD
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
1300000 USD
CY2021Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
6800000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
9500000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
8900000 USD
CY2022Q1 us-gaap Other Liabilities
OtherLiabilities
1200000 USD
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
77800000 USD
CY2021Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
56700000 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
705300000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
704500000 USD
CY2022Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
410000000 USD
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
600000000 USD
CY2022Q1 for Letterof Credit Maximum Borrowing Capacity
LetterofCreditMaximumBorrowingCapacity
100000000 USD
CY2022Q1 for Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment
LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment
0.50
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2022Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
60500000 USD
CY2022Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
349500000 USD
CY2020Q2 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 USD
CY2022Q1 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
47800000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
28400000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
88300000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
50400000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49820937 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48412213 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49752153 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48270718 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
57229 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
97711 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
53364 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
80692 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49878166 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48509924 shares
CY2021Q1 for Numberof Lots Sold
NumberofLotsSold
3588 Lot
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49805517 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48351410 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.96
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28400000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16300000 USD
CY2021Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
64400 Lot
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.245
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2022Q1 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
21900000 USD
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1100000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
23000000 USD
CY2021Q3 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
23200000 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1200000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24400000 USD
CY2021Q4 for Equity Securities Registered Value
EquitySecuritiesRegisteredValue
750000000 USD
CY2021Q4 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
300000000 USD
for At The Market Equity Offering Program Common Stock Issued
AtTheMarketEquityOfferingProgramCommonStockIssued
84547 shares
for At The Market Equity Offering Program Net Proceeds
AtTheMarketEquityOfferingProgramNetProceeds
1700000 USD
CY2022Q1 for Numberof Lots Sold
NumberofLotsSold
5788 Lot
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
100000 USD
CY2022Q1 for At The Market Equity Offering Program Common Stock Issued
AtTheMarketEquityOfferingProgramCommonStockIssued
0 shares
CY2022Q1 for Common Stock Availablefor Issuance Value Remaining
CommonStockAvailableforIssuanceValueRemaining
748200000 USD
CY2022Q1 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
298200000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
394786 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.76
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
900000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1200000 USD
CY2022Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
60500000 USD
CY2022Q1 us-gaap Special Assessment Bond
SpecialAssessmentBond
570800000 USD
CY2022Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
64200 Lot
for Numberof Lots Sold
NumberofLotsSold
10304 Lot
for Numberof Lots Sold
NumberofLotsSold
7155 Lot
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233700000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153600000 USD

Files In Submission

Name View Source Status
0001406587-22-000070-index-headers.html Edgar Link pending
0001406587-22-000070-index.html Edgar Link pending
0001406587-22-000070.txt Edgar Link pending
0001406587-22-000070-xbrl.zip Edgar Link pending
a3312022exhibit311.htm Edgar Link pending
a3312022exhibit312.htm Edgar Link pending
a3312022exhibit321.htm Edgar Link pending
a3312022exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
for-20220331.htm Edgar Link pending
for-20220331.xsd Edgar Link pending
for-20220331_cal.xml Edgar Link unprocessable
for-20220331_def.xml Edgar Link unprocessable
for-20220331_g1.jpg Edgar Link pending
for-20220331_htm.xml Edgar Link completed
for-20220331_lab.xml Edgar Link unprocessable
for-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending